Myo-inositol for preventing gestational diabetes

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 2, 2015, Pages

  Brown, Julie ^a   Crawford, Tineke J ^a   Alsweiler, Jane ^b   Crowther, Caroline A ^a,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL;

ARTICLE; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG SAFETY; HUMAN; MULTIPLE PREGNANCY; OUTCOME ASSESSMENT; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 85008229096     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011507     Document Type: Article

References (29)

1. Carlomagno G, Unfer V, Buffo S, D'Ambrosio F. Myo-inositol in the treatment of premenstrual dysphoric disorder. Human Psychopharmacology: Clinical and Experimental 2011;26(7):526-30.
2. Corrado F, D'Anna R, Di Vieste G, Giordano D, Pintaudi B, Santamaria A, et al.The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine 2011;28:972-5.
3. Crane M, Bain E, Tieu J, Han S, Middleton P, Crowther CA. Diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD010443]
4. D'Anna R, Di Bendetto V, Rizzo P, Raffone E, Interdanto ML, Corado F, et al.Myo-inositol may prevent gestational diabetes in PCOS women. Gynecological Endocrinology 2012;28(6):440-2.
5. Ferrara A. Increasing prevalence of gestational diabetes mellitus. Diabetes Care 2007;30 (Suppl. 2):S141-S146.
6. Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovarian syndrome. Gynecological Endocrinology 2008;24:139-44.
7. Glueck CJ, Pranikoff J, Aregawi D, Wang P. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovarian syndrome. Fertility and Sterility 2008;89:625-34.
8. McMaster University. GRADEpro. [Computer program on www.gradepro.org]. 2014. McMaster University, 2014.
9. Han S, Crowther CA, Middleton P. Exercise for pregnant women for preventing gestational diabetes mellitus. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD009021.pub2]
10. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
11. Kennington AS, Hill CR, Craig J, Bogardus C, Raz I, Ortmeyer HK, et. al. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. New England Journal of Medicine 1990;323:373-8.
12. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-8.
13. Metzger BE, Coustan DR. Proceedings of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21 (Suppl. 2):B1-B167.
14. Minozzi M, D'Andrea G, Unfer V. Treatment of hirsutism with myo-inositol: a prospective clinical study. Reproductive Biomedicine Online 2008;17(4):579-82.
15. Moore TR. Diabetes Mellitus and Pregnancy. http://emedicine.medscape.com/article/127547-overview [accessed 27 Jan 2014].
16. Nankervis A, Conn J. Gestational diabetes mellitus-negotiating the confusion. Australian Family Physician 2013;42(8):528-31.
17. NCI Dictionary of Cancer Terms. http://www.cancer.gov/dictionary (accessed July 2014).
18. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. New England Journal of Medicine 1999;340:1314-20.
19. National Institute for Health and Clinical Excellence. Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period.. Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period. Manchester: NICE, 2008.
20. Nordio M, Pajalich R. Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis. Journal of Thyroid Research 2013;Article ID 424163:5 pages. [DOI: 10.1155/2013/424163]
21. Papaloe E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C, et al.Myoinositol in patients with polycystic ovarian syndrome: a novel method for ovulation induction. Gynecological Endocrinology 2007;23:700-3.
22. Pettitt DJ, Baird HR, Aleck KA, Bennett PH, Knowler WC. Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. New England Journal of Medicine 1983;308:242-5.
23. Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC. Congenital susceptibility to NIDDM: role of intrauterine environment. Diabetes 1988;37:622-8.
24. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
25. Schunemann HJ. GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice [GRADE: Von der Evidenz zur Empfehlung.Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 2009;103(6):391-400.
26. Silverman BL, Rizzo TA, Cho NH, Metzger BE. Long-term effects of the intrauterine environment: The Northwestern University Diabetes in Pregnancy Center. Diabetes Care 1998;21 (Suppl. 2):B142-B149.
27. Suzuki S, Kawasaki H, Satoh Y. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type 2 diabetes. Diabetes Care 1994;17:1465-8.
28. Tieu J, Crowther CA, Middleton P. Dietary advice in pregnancy for preventing gestational diabetes mellitus. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD006674.pub2]
29. Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecological Endocrinology 2011;27:857-61.